Sponsor

Aeris Therapeutics

Clinical research sponsor

Published trials17
Recruiting shown0
Roles1
SourceClinicalTrials.gov

Clinical trials

17 shown
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous EmphysemaNCT01908933 · lead sponsor · 2013-09-01
WITHDRAWN
Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)NCT01449292 · lead sponsor · 2012-06-01
TERMINATED
Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant EmphysemaNCT01520740 · lead sponsor · 2012-02-01
TERMINATED
Post Market Registry Study of the AeriSeal SystemNCT01520064 · lead sponsor · 2012-02-01
TERMINATED
A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced EmphysemaNCT01320566 · lead sponsor · 2011-03-01
TERMINATED
A Registry Study of the AeriSeal® System or Lung Volume Reduction in Patients With Advanced EmphysemaNCT01449175 · lead sponsor · 2011-01-01
TERMINATED
AeriSeal® System for Lung Volume Reduction in Patients With Advanced EmphysemaNCT01181466 · lead sponsor · 2010-08-01
COMPLETED
AeriSeal System for Lung Volume ReductionNCT01051258 · lead sponsor · 2009-11-01
COMPLETED
Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) EmphysemaNCT00716053 · lead sponsor · 2008-12-01
WITHDRAWN
Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous StudyNCT00630227 · lead sponsor · 2008-02-01
COMPLETED
US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyNCT00515164 · lead sponsor · 2007-08-01
COMPLETED
Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema StudyNCT00517998 · lead sponsor · 2007-05-01
COMPLETED
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema StudyNCT00435253 · lead sponsor · 2007-02-01
COMPLETED
US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema StudyNCT00347659 · lead sponsor · 2006-06-01
COMPLETED
Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial FormulationNCT00205920 · lead sponsor · 2005-05-01
TERMINATED
US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial FormulationNCT00085852 · lead sponsor · 2005-04-01
COMPLETED
Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial FormulationNCT00205907 · lead sponsor · 2005-01-01
TERMINATED

Sponsor roles

lead sponsor17

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.